# CORRESP — ONCOLYTICS BIOTECH INC  (ONCY)  (CIK 0001129928)

> <strong>ONCOLYTICS BIOTECH INC  (ONCY)  (CIK 0001129928) → SEC staff</strong> · filed 2026-04-01 · ticker ONCY · SIC 2834

## What is this

A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

## Key facts

- **Accession number:** 0001104659-26-038540
- **Form:** CORRESP
- **Filer:** ONCOLYTICS BIOTECH INC  (ONCY)  (CIK 0001129928)
- **CIK:** 0001129928
- **Ticker:** ONCY
- **Filed:** 2026-04-01
- **SIC industry:** 2834
- **HQ:** San Diego, CA

## Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1129928/000110465926038540/filename1.htm

EDGAR review history for this filer: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1129928&type=UPLOAD&dateb=&owner=include&count=40

## Other comment-letter activity for ONCOLYTICS BIOTECH INC  (ONCY)  (CIK 0001129928)

- UPLOAD — 2026-04-01 — /comment-letter/0000000000-26-003301
- CORRESP — 2025-12-05 — /comment-letter/0001104659-25-118931

## Citation

> US Securities and Exchange Commission, EDGAR CORRESP comment letter, ONCOLYTICS BIOTECH INC  (ONCY)  (CIK 0001129928) (CIK 0001129928), filed 2026-04-01, accession 0001104659-26-038540. Retrieved via MORVS 2026-11-04 from https://api.morvs.ai/comment-letter/0001104659-26-038540.

---

*[SEC comment letters dataset](/datasets/sec-comment-letters) · CC0 1.0*